Advertisement

Topics

Search Results for "Arbonne Annual Revenue 2012"

19:46 EST 16th January 2017 | BioPortfolio

Matching Channels

macitentan

Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic systemic disease characterized by progressive joint deformity and joint destruction driven by synovial inflammation and hyperplasia in which cytokines play cen...

GE Healthcare

Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is i...

Matching News

Arbonne International Expands Into Asia With Opening Of Arbonne Taiwan

IRVINE, Calif., Nov. 1, 2016 /PRNewswire/ -- Arbonne International, LLC (Arbonne) officially opens for business in Taiwan in one week, on November 8, 2016. Taiwan is Arbonne's first country...

Medication Nonadherence Causes Pharmaceutical Companies to Lose $637 Billion in Revenue Annually

NORWALK, Conn., Nov. 16, 2016 /PRNewswire/ — HealthPrize Technologies today announced the publication of an update to a research paper co-authored with Capgemini estimating annual pharmaceutical...

SMP Pharmacy Solutions Recognized as one of the Region's Top 50 Fastest-Growing Private Companies

MIAMI, FL -- (Marketwired) -- 09/09/16 -- The South Florida Business Journal announced that SMP Pharmacy Solutions is the number three fastest-growing private company in South Florida in the Revenue ...

Robust Trading Helps BTG to Raise Full-Year Revenue Guidance

BTG Plc has raised its revenue estimate for the year ended 31 March 2012 to £190 - £195 million from the previous guidance of £160 - £165 million due to the robust trading in the Licensing & B...

Cerner Edges Annual Revenue Guidance Lower

Health-care information technology firm Cerner Corp. on Tuesday gave cautious guidance for the second straight quarter and edged its revenue outlook lower for the year.

Pharma's non-adherence problem is growing

An updated report pegs total global revenue loss at an incredible $637 billion, up nearly 13% from 2012. 

Mallinckrodt revenue boosted by higher volumes

Other players in the pharmaceutical industry have recently raised questions about how long hefty annual price-hikes for drugs will continue. Mallinckrodt said its generics segment posted a 19% revenue...

Vertex Pharmaceuticals revenue outlook for cystic fibrosis treatments

Jan 8 Vertex Pharmaceuticals Inc said on Sunday that it expected full-year 2017 revenue from its Orkambi cystic fibrosis treatment of $1.1 billion to $1.3 billion and revenue from its Kalydeco treatme...

Matching PubMed Articles

Hydro-Climatological Influences on Long-Term Dissolved Organic Carbon in a Mountain Stream of the Southeastern United States.

In the past decade, significant increases in surface water dissolved organic carbon (DOC) have been reported for large aquatic ecosystems of the Northern Hemisphere and have been attributed variously ...

National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.

Several studies revealed the epidemiology of Kawasaki disease-related hospitalizations among children in the USA and other countries. However, disparities of developing coronary artery aneurysms by ra...

The fourth annual meeting of the American College of Professional Neuropsychology (ACPN) poster roster, March 9-10, 2012, Las Vegas, Nevada.

Biohydrogen production from waste bread in a continuous stirred tank reactor: A techno-economic analysis.

Biohydrogen production from waste bread in a continuous stirred tank reactor (CSTR) was techno-economically assessed. The treating capacity of the H2-producing plant was assumed to be 2 ton waste brea...

A Quantitative Analysis of Cold Water for Human Consumption in Hospitals in Spain.

An estimation of the water used for human consumption in hospitals is essential to determine possible savings and to fix criteria to improve the design of new water consumption models. The present wor...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement